Srinivas Akkaraju - Dec 21, 2023 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role
Director
Signature
/s/ Srinivas Akkaraju
Stock symbol
SYRS
Transactions as of
Dec 21, 2023
Transactions value $
$3,999,998
Form type
4
Date filed
12/26/2023, 05:24 PM
Previous filing
Nov 13, 2023
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYRS Common Stock Purchase $4M +905K +102.67% $4.42 1.79M Dec 21, 2023 By Samsara BioCapital, L.P. F1
holding SYRS Common Stock 2.67K Dec 21, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.